Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Fibroblasts are a dynamic cell type that achieve selective differentiated states to mediate acute wound healing and long-term tissue remodeling with scarring. With myocardial infarction injury, cardiomyocytes are replaced by secreted extracellular matrix proteins produced by proliferating and differentiating fibroblasts. Here, we employed 3 different mouse lineage-tracing models and stage-specific gene profiling to phenotypically analyze and classify resident cardiac fibroblast dynamics during myocardial infarction injury and stable scar formation. Fibroblasts were activated and highly proliferative, reaching a maximum rate within 2 to 4 days after infarction injury, at which point they expanded 3.5-fold and were maintained long term. By 3 to 7 days, these cells differentiated into myofibroblasts that secreted abundant extracellular matrix proteins and expressed smooth muscle α-actin to structurally support the necrotic area. By 7 to 10 days, myofibroblasts lost proliferative ability and smooth muscle α-actin expression as the collagen-containing extracellular matrix and scar fully matured. However, these same lineage-traced initial fibroblasts persisted within the scar, achieving a new molecular and stable differentiated state referred to as a matrifibrocyte, which was also observed in the scars of human hearts. These cells express common and unique extracellular matrix and tendon genes that are more specialized to support the mature scar.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and resemble POSTN-expressing matrifibrocytes7.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We used an Ang II/PE infusion model to study cardiac fibrosis which has inherent limitations3,4,7,39”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Computational lineage analysis predicted that FAP expression marks a fibroblast trajectory that transitions into populations including POSTN + matrifibrocytes 32 and myofibroblasts.”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Deaths: Leading Causes for 2017.
Heron, M. P. (2019) · PubMed · Cited by 2,406
Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis
Joe, A. W. B., Yi, L., Natarajan, A., Le Grand, F., So, L., Wang, J., Rudnicki, M. A., & Rossi, F. M. V. (2010) · Nature Cell Biology · doi:10.1038/ncb2015 · Cited by 1,690
Revisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
Murphy, M. M., Lawson, J. A., Mathew, S. J., Hutcheson, D. A., & Kardon, G. (2011) · Development · doi:10.1242/dev.064162 · Cited by 1,249
Darby, I. A., Skalli, O., & Gabbiani, G. (1990) · PubMed · Cited by 1,189
Kajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 5×
“We previously showed that myofibroblasts in the heart can dedifferentiate and revert back to an “uninjured” state after a cardiac stress response resolves, such as with Ang II/PE agonist infusion and then its removal (23).”
BackgroundInfluentialSelf-citationBryant, S. J., & Anseth, K. S. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.1217 · Cited by 845
Research works printed but not linked: 1
- 28. Ubil E, et al. Mesenchymal-endothelial transition contributes to cardiac neovascularization. Nature. 2014;514(7524):585–590. doi: 10.1038/nature13839. · DOI · Paper page
Cited by
Items 601–638 of 638
Killing of Gold Nanorods-Loaded Human Cardiac Fibroblasts Mediated by Photo-Thermal Activation
Floris, E., Pompeo, F., Picchio, V., Miglietta, S., Mei, V. D., Cozzolino, C., Icolaro, F., Petrozza, V., Frati, G., Petronella, F., et al. (2026) · ACS Omega · doi:10.1021/acsomega.5c12235
WISP1 drives a mechanically active immune modulatory and proliferative cardiac myofibroblast statePreprint
Parkins, S., Anthony, S., Goldsworthy, T. K., Nigam, A., Schehl, N. C., Jaggers, R. M., Kasprovic, D. A., Green, L. C., Kanisicak, O., & Tranter, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.17.706476
“These activated myofibroblasts serve as the primary source of interstitial collagen types I and III, fibronectin, and matrix metalloproteinases (MMPs) required for scar formation [17, 18].”
Self-citationDholaniya, P. S., Islam, H., Alvi, S. B., Mergaye, M., Kanisicak, O., & Khan, M. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-41631-y
“The increased expression of ECM proteins at Wk-1 post-MI followed by the overexpression of bone/cartilage genes at Wk-4 has previously been reported in FBs 59 .”
Self-citationIbrahim, S., & Bagchi, R. A. (2026) · Research Square · doi:10.21203/rs.3.rs-9098586/v1
Cardiac Fibrosis: Mechanobiology, Epigenetics, and the Path to Precision Therapy
Hamouz, M., Hammouz, R. Y., Caruana, C., Micallef, D., Bednarek, A. K., & Dingli, P. F. (2026) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-026-00896-z
Molecular Regulation of Cardiomyocyte Cell Cycle and Regeneration
Li, F., Son, Y., Yang, M., & Zhu, W. (2026) · Biology · doi:10.3390/biology15070568 · Cited by 1
“Genetic ablation of Postn -positive myofibroblasts or disruption of fibroblast-to-myofibroblast transition through muscleblind-like splicing regulator 1 compromise scar formation and lead to ventricular rupture, highlighting the essential structural role of myofibroblasts in acute repair [184–187].”
Suppressing p16INK4a promotes lung regeneration through a fibroblast lipogenic switch
Zysman, M. (2019) · theses.fr (ABES) · doi:10.70675/c507eaa0z188ez4332z952az2c54118917d6
礒野, 高., 洲崎, 雅., 窪田, 成., 影山, 進., 河内, 明., Isono, T., MATSUMOTO, T., Suzaki, M., Kubota, S., KAGEYAMA, S., et al. (2022) · Institutional Repositories DataBase (IRDB)
The role of MEIS inhibitors in cardiac regeneration and protection
Mammadova, A. (2024) · theses.fr (ABES) · doi:10.70675/26f419bdzeecdz4816z8ff0z9800989c228b
Contribution of Cardiac CD34⁺ Stromal Cells to Post-Myocardial Infarction Repair in Middle-Aged Rats
Schneider, D. T., & Dedkov, E. I. (2026) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554261434317
In vivo CRISPR-mediated activation of cardiogenic genes to reprogram cardiac fibroblasts
Dutta, S., Chen, S., Ahmad, W., Huang, W. C., Wang, Y., & Liang, J. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1812941
Multicellular Cross Talk and Therapeutic Vaccines in Heart Failure
Katoh, M., Nomura, S., Ko, T., Komuro, J., Hayashi, H., Nakagami, H., & Komuro, I. (2026) · Physiology · doi:10.1152/physiol.00007.2026
CDCP1 Deletion Protects Against Pressure Overload-Induced Cardiac Dysfunction and Fibrosis in MicePreprint
Pereira, N., Ghazal, R., Srinivas, A. N., wang, M., Cao, J. J. L., Wang, L., Marín-Goñi, I., Sherman, W., John, A., Vyas, H., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9236741/v1
“20,21 These populations, which express Thbs4 , Cilp , Postn , and Cthrc1 , represent a pressure overload-specific fibroblast state distinct from classical α-SMA + myofibroblasts observed after myocardial infarction.”
Ford, K., Abbay, H., Leonardson, A. S., Franks, J. M., & Chavkin, N. W. (2026) · Basic Research in Cardiology · doi:10.1007/s00395-026-01190-9
“POSTN is a well-established marker of fibroblast activation and myofibroblast differentiation that promotes myocardial fibrosis following ischemia [24, 56, 57].”
Zhang, F., Liu, Y. H., Liu, R., Li, B., & Li, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1801258 · Cited by 1
“Myo fi broblasts are characterized by the expression of a -smooth muscle actin ( a -SMA), formation of stress fi bers, and acquisition of strong contraction, migration, proliferation and ECM synthesis capabilities (76, 77).”
Preclinical evaluation of cysteine protease-inhibitor aloxistatin (E64d) for heart failure therapy
Jordan, M., Stucki-Koch, A., Schinke, M., Willmer, L., Senne, I., Abbas, N., Bentele, M., Oldenkott, D., Lachmann, N., Feldbrügge, L., et al. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-026-02695-5 · Cited by 1
“The result - ing myocardial stiffening impairs electrical conduction and diastolic or systolic function, resulting in progressive loss of cardiac performance [6 – 9].”
Fibroblast MrgprX2/B2 signaling drives hypertrophic scar fibrosis
Xu, H., Sheng, M., Jia, Y., Luo, Y., Wu, L., Zhou, L., Wang, Z., Sun, J., Shen, T., Zhou, L., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117616
Restraining fibrosis in cardiac repair
Huang, S., & Frangogiannis, N. G. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag107
Cartilage intermediate layer protein (CILP) in cardiac fibrosis: Protective or pathogenic?
Corrales-Terrón, M., Rossi, C., Krause, J., Schroen, B. L. M., Herum, K. M., & van Nieuwenhoven, F. A. (2026) · Matrix Biology · doi:10.1016/j.matbio.2026.102032 · Cited by 1
Afanasiev, S. A., ZAKOPAYKO, B. A., Kondratieva, D. S., Zemlyanoy, D. A., Raguzina, D. V., & Popov, S. V. (2026) · Russian Journal of Transplantology and Artificial Organs · doi:10.15825/1995-1191-2026-2-188-201
Mimouni, M., DARLET, S., Jover, B. F., Gayrard, N., Jeanson, L., Blanchard, M., Lajoix, A., & Desmetz, C. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08589-x
“Moreover, diverse fibroblast populations involved in heart injury and disease have been identified by genetic lineage tracing [63] and single-cell RNA sequencing [64].”
Nastase-Rusu, E.-G., Lupan, A., Preda, M. B., & Burlacu, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156630
“Other approaches use flow cytometry-based enrichment, reporter mice, selective adhesion, FACS, or magnetic separation to improve specificity [4,12–15].”
Su, Z., Shen, H., Sun, J., Kong, X., & Sun, W. Y. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.049049
“6,7 These cells increase tissue stiffness, impair myocardial contractility, and further compromise cardiac function.”
Single-Cell Profiling of Dynamic Epicardial Cell States During Myocardial InfarctionPreprint
Wong, D., Cheng, J., Yang, X., & Quijada, P. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.31.748312
Pan, Y., Zhong, J., Mo, X., Zhang, C., Li, S., Shi, X., Ning, X., Liu, X., Shi, X., He, J., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.181539
Wu, J., Yang, C., Wu, D., Zhu, S., Liu, Y., Yang, Y., Ze, X., Xu, Y., Yang, X., Mao, L., et al. (2026) · Circulation · doi:10.1161/circulationaha.126.078415
Cardiac fibrosis: mechanistic insights and translational advances
Xie, H.-Y., Zheng, X.-T., Wang, X.-H., Yang, J.-Y., Liu, Y.-X., Zhao, Y., Tang, H., & Hu, H.-J. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00587-1 · Cited by 1
“Fibroblast activation during cardiac fibrosis is similarly dynamic, giving rise to distinct cellular states at different stages of scar formation [24, 25].”
Chen, T., Ding, S., Zhang, Z., Zhao, L., Cao, K., Zhang, G., Weng, C., Gong, G., Xu, L., Yang, M., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14092089
Zambrano, M. A., Bayer, A. L., Ramos, R. B., Stortini, C., Kaur, K., Bedi, K., Margulies, K. B., & Alcaide, P. (2026) · The American Journal of Pathology · doi:10.1016/j.ajpath.2026.08.007
Identification of αSMA lineage cells in the posterior limbal stroma
Xiao, Y.-T., Barre-Nguyen, S., Matthews, B. G., Kalajzić, I., Cao, Y., McGhee, C. N. J., & Zhang, J. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111259
Wang, M., Li, X., Gao, M., Zhu, B., 维铁柱, Huang, W., Fan, X., & Liao, J. (2026) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(26)61214-9
Cardiac nanomedicine for ischemic injury and remodeling: imaging and therapy
Zhang, W., Zeng, X.-L., Himly, M., Li, Y., & Zhang, G. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2742413
Fortuna, I., Quelhas‐Santos, J., Soeiro, P., Machado, R. B., Oliveira, A., Pereira, J., Limongelli, G., Faria, T., & Martins, E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198901
“Cardiomyocytes, endothelial cells, pericytes, macrophages, lymphocytes, and mast cells also modulate the fibrotic response through paracrine signalling, protease release, and regulation of fibroblast function [6,20].”
Kuznetsov, I. A., Li, K., Guedira, Y., Simonson, B., Chaffin, M. D., Aberra, Y. T., Bedi, K. C., Thome, T., Yang, Y., Branch, K., et al. (2026) · Nature Cardiovascular Research · doi:10.1038/s44161-026-00885-5 · Cited by 1
Interferon signaling in myocardial infarction: mechanistic insights and translational prospects
Xu, S., Liu, Y., Zhu, M., Xu, F., & Liu, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1914545
Wang, Y., & Luo, Y. (2026) · Cells · doi:10.3390/cells15201869
“After myocardial injury, fibroblasts undergo marked spatial and functional changes and contribute to matrix deposition and scar formation [53,54].”
Hepatocyte-derived selenoprotein P contributes to pressure overload–induced cardiac remodeling
Usui, S., Takashima, S., Inoue, O., Goten, C., Takeda, Y., Hashimuko, D., Yamaguchi, K., Shinjo, Y., Nomura, A., Takamura, T., et al. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102854
“Cardiac fibrosis is a key determinant of HF progression and is characterized by excessive extracellular matrix (ECM) deposition [25].”
陆红, Tao, X.-L., Song, D.-M., He, Y., & Zheng, L.-Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1992368
“In pancreatic cancer, in fl ammatory fi broblasts and myo fi broblastic CAFs represent distinct functional states with different spatial distributions and secretomes (51), just as the post-MI heart harbors parallel myo fi broblast and matri fi brocyte-like populations (4, 8).”
Influential
Metadata
- Authors
- Fu, X., Khalil, H., Kanisicak, O., Boyer, J. G., Vagnozzi, R. J., Maliken, B. D., Sargent, M. A., Prasad, V., Valiente-Alandi, I., Blaxall, B. C., & Molkentin, J. D.
- Affiliations
- Louisiana State University (US)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Molkentin, Jeffery D.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2018-04-16
- Volume
- 128
- Issue
- 5
- Pages
- 2127-2143
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5957472
- OpenAlex
- W2800350399
- Cited by
- 636
- References
- 54
- Citations by year
- 2026: 58 · 2025: 81 · 2024: 71 · 2023: 93 · 2022: 87 · 2021: 86 · 2020: 90 · 2019: 52 · 2018: 17
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Funders
- National Institutes of Health (R01 HL142217)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Keywords
- cardiac fibroblasts, myocardial infarction, scar formation, myofibroblasts, fibroblast differentiation, lineage tracing, extracellular matrix, smooth muscle actin, collagen, cardiac remodeling, wound healing
- MeSH terms
- Animals, Cell Differentiation, Cicatrix, Extracellular Matrix, Female, Humans, Male, Myocardial Infarction, Myocardium, Extracellular Matrix Proteins, Myoblasts, Cardiac, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.